| scholarly article | Q13442814 |
| P50 | author | Clare Lendrem | Q47158646 |
| P2093 | author name string | Jean Norden | |
| Matthew Collin | |||
| Xiao-Nong Wang | |||
| Wei Cope | |||
| Sadaf Atarod | |||
| Anne Mary Dickinson | |||
| Kim Frances Pearce | |||
| Mohammed Mahid Ahmed | |||
| P2860 | cites work | miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice | Q24595073 |
| The microRNA.org resource: targets and expression | Q24650094 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells | Q33595180 | ||
| NF-κB Down-regulates Expression of the B-lymphoma Marker CD10 through a miR-155/PU.1 Pathway | Q34143653 | ||
| Identification of reference microRNAs and suitability of archived hemopoietic samples for robust microRNA expression profiling. | Q34231622 | ||
| Differential activation and functional specialization of miR-146 and miR-155 in innate immune sensing | Q34311065 | ||
| Molecules and mechanisms of the graft-versus-leukaemia effect | Q34318010 | ||
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report | Q34474243 | ||
| Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses | Q34626052 | ||
| MiR-146a in Immunity and Disease | Q35430738 | ||
| Regulation of acute graft-versus-host disease by microRNA-155. | Q36010229 | ||
| MicroRNAs and immunity: tiny players in a big field | Q36739025 | ||
| Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients | Q36955334 | ||
| microRNAs and the immune response | Q37178538 | ||
| Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease | Q37291611 | ||
| miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. | Q37454160 | ||
| Evidence for microRNA-mediated regulation in rheumatic diseases | Q37649034 | ||
| MicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis | Q38052464 | ||
| Suggestions on the use of statistical methodologies in studies of the European Group for Blood and Marrow Transplantation | Q38086718 | ||
| Macrophage development from HSCs requires PU.1-coordinated microRNA expression. | Q39512425 | ||
| Cytokine dysregulation as a mechanism of graft versus host disease | Q40780265 | ||
| MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation | Q40942018 | ||
| The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. | Q41052928 | ||
| MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD. | Q41745800 | ||
| Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes | Q45059138 | ||
| miR-155 in acute myeloid leukemia: not merely a prognostic marker? | Q45821493 | ||
| Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. | Q52567432 | ||
| The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia | Q57615556 | ||
| MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins | Q83586463 | ||
| Serum microRNA155 is increased in patients with acute graft-versus-host disease | Q87228418 | ||
| P304 | page(s) | 56 | |
| P577 | publication date | 2016-03-08 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence | |
| P478 | volume | 7 |
| Q49679320 | Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy |
| Q37734489 | Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes |
| Q57116991 | Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy |
| Q89965567 | Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD |
| Q91657527 | MicroRNAs in graft-versus-host disease: a review of the latest data |
| Q90916358 | New therapeutic perspectives to manage refractory immune checkpoint-related toxicities |
| Q55396614 | Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation. |
| Q36130498 | Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation |
| Q41105711 | Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat. |
Search more.